2022 MMIT Patient Choice Awards Finalist

Senderra is a 2022 MMIT Patient Choice Awards Finalist!

About MMIT

MMIT brings therapies from the pipeline to the patient. They identify barriers to patient access and work closely with major stakeholders to ensure that therapies are covered by payers.

MMIT's product portfolio reflects years of listening to clients, combined with the expertise of pharmacists, clinicians, data specialists, and market researchers.

7th Annual MMIT Patient Choice Awards

Senderra is a finalist in the Managed Markets Insight & Technology (MMIT) seventh-annual Specialty Pharmacy Patient Choice Awards as ranked by patient satisfaction survey results from the previous year.

Each year, MMIT recognizes specialty pharmacies that provide best-in-class customer satisfaction and overall patient care.

There are a total of four categories: Payer/ PBM, Hospital and Health System, Independent and Retail. The finalists and winners are calculated based on the highest average net promoter scores (NPS) from quarterly Zitter Insights Specialty Pharmacy Patient Satisfaction surveys.

Senderra is a 2022 MMIT Award Finalist

Senderra is honored to be a finalist this year in the Independent Specialty Pharmacy category. This honor confirms Senderra’s ongoing commitment to keeping people first and providing exceptional patient care.

About senderra

Senderra is a national specialty pharmacy, serving patients with challenging and ongoing medical conditions through provision of specialty medications, clinical expertise and support services. 

We dedicate ourselves to designing and executing a model to serve the needs of our patients and partners (Prescribers, Pharma and Payers) in order to make a difference and effect positive outcomes.